Medical News

RSS

Sodium Stibogluconate & Paromomycin combination treatment for Kala azar

East Africa is fighting the worst kala azar outbreak in a decade. Collaboration across the region through the Leishmaniasis East Africa Platform (LEAP) has resulted in the development of a new combination therapy (SSG&PM) which is cheaper and nearly halves the length of treatment from a 30 day course of injections to 17 days.

26 Sep 2011

New research reveals how brain devotes time to reflect on tough choices

Take your time. Hold your horses. Sleep on it. When people must decide between arguably equal choices, they need time to deliberate. In the case of people undergoing deep brain stimulation (DBS) for Parkinson's disease, that process sometimes doesn't kick in, leading to impulsive behavior. New research into why that happens has led scientists to a detailed explanation of how the brain devotes time to reflect on tough choices.

26 Sep 2011

Britain’s health workers urged to get flu shots to protect patients

Britain’s National Health Service (NHS) is urging its staff to take their flu shots amid fresh warnings that low vaccination rates among health professionals could lead to vulnerable patients getting infected and dying. The NHS's employers, health trade unions and the Department of Health have launched a campaign to tackle low immunization rates among frontline staff such as doctors and nurses.

26 Sep 2011

Poor diet and mental health problems linked in teenagers: Study

Teenagers who eat healthy diets including fruits and vegetables have lower rates of mental health problems, a study shows. A study of 3,000 adolescents has found that those who had poor diets filled with junk and processed foods were more likely to suffer mental health problems such as depression and anxiety.

26 Sep 2011

Administration faces Monday deadline on health lawsuit

Obama administration lawyers face a decision by Monday that carries a high political risk and will probably determine whether the Supreme Court decides on the constitutionality of the healthcare law before next year's presidential election. ... Under the appeals court's rules, the Justice Department must notify the 11th Circuit by Monday whether it will seek a full court review.

26 Sep 2011

SAMHSA announces 20 new grants to help reduce chronic homelessness

The Substance Abuse and Mental Health Services Administration (SAMHSA) announced today 20 new grants totaling up to $27.7 million, over three years, to local organizations working to reduce chronic homelessness in their communities.

26 Sep 2011

Gene blockade could reverse type 2 diabetes: Study

Australian scientists report that they may be on the brink of reversing type 2 diabetes after a genetic discovery. The finding centers on how a particular gene responds to high-fat diets by disrupting insulin production in the pancreas and triggering diabetes.

26 Sep 2011

Rotavirus vaccine saved 65,000 hospitalizations and $278 million in healthcare costs: Study

The latest research shows that since the 2006 introduction of routine inoculation against rotavirus -- a leading cause of diarrhea in infants and young children -- almost 65,000 fewer American children have been hospitalized and about $278 million in healthcare costs have been saved.

26 Sep 2011

Listeria contamination in cantaloupes shipped to 10 states

Listeria-contaminated cantaloupes were shipped to five more states than was previously known, bringing to 22 the total number of states affected by an outbreak that killed eight people, the FDA announced last week.

26 Sep 2011

Embryonic stem cell therapy for incurable Stargardt eye disease

...

26 Sep 2011

Primatene inhalers to be phased out this December: FDA

According to the Food and Drugs Administration (FDA), the Armstrong Pharmaceutical's Primatene mist inhaler will be discontinued on Dec. 31, and prescription inhalers are the only alternative to the over-the-counter asthma drug.

26 Sep 2011

Researchers discover 16 genes linked with breast cancer prognosis

Researchers at Wake Forest Baptist Medical Center have made a discovery that brings them one step closer to being able to better predict which patients have the best chance of surviving breast cancer.

26 Sep 2011

The Journal of Pain publishes results from Butrans Transdermal System Phase 3 clinical study

Butrans (Buprenorphine) Transdermal System CIII 20 mcg/hour provided significantly lower "average pain over the last 24 hours" scores compared to Butrans 5 mcg/hour when used in opioid-experienced patients with moderate-to-severe chronic low back pain, according to a pivotal Phase 3 clinical study published in the online, August issue of The Journal of Pain.

26 Sep 2011

Study highlights individual and combined effect of obesity on asthma development

Belly fat, known clinically as central obesity, has been linked to the development of asthma in a new study.

26 Sep 2011

First Radium-223 Chloride Phase III study in prostate cancer

Until recently, options for patients with bone metastases from advanced prostate cancer have been very limited. But now the first Phase III study of an alpha-pharmaceutical in these patients has shown that it can prolong survival significantly, according to research reported today (Saturday) at the 2011 European Multidisciplinary Cancer Congress.

26 Sep 2011

VDF honors physicians, leaders in the field of vascular disease with President's Awards

The Vascular Disease Foundation (VDF) presented its annual awards at the organization's eighth annual meeting in Washington. The awards honor the work of citizens, health care providers, organizations, researchers and companies that have enhanced the understanding and/or treatment of peripheral vascular diseases.

26 Sep 2011

EMA CHMP adopts positive opinion for Optimer's DIFICLIR to treat C. difficile infection

Optimer Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for DIFICLIR (fidaxomicin) tablets for the treatment of adults suffering with a Clostridium difficile infection (CDI), also known as C. difficile-associated diarrhea.

26 Sep 2011

University of Utah develops video game to help children with cancer

Even super heroes need a chance to get better, especially if they've been fighting their arch-nemesis and a robotic crab that just won't go away. At least, that's the premise behind a video game developed at the University of Utah to help children with cancer during their treatment.

26 Sep 2011

Combination of everolimus, exemestane holds promise against post-menopausal breast cancer

Results from a phase III clinical trial have shown that combining two existing cancer drugs to treat post-menopausal women with advanced breast cancer resistant to hormonal therapy significantly improves outcome.

26 Sep 2011

CytoDyn files provisional patent application for humanized version of Cytolin to treat HIV

CytoDyn Inc., a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, HIV/AIDS, announced today that it has filed a provisional patent application in the United States for its humanized version of its lead product Cytolin, a monoclonal antibody for the treatment of HIV infection.

26 Sep 2011